Literature DB >> 6160629

The role of prophylactic gastrojejunostomy for unresectable periampullary carcinoma.

S W Blievernicht, J P Neifeld, J J Terz, W Lawrence.   

Abstract

One hundred and fifteen patients undergoing palliative bypass for unresectable periampullary carcinoma were reviewed. Postoperative mortality and subsequent length of survival correlated with both presenting symptoms and operative findings. Among 93 patients presenting with biliary obstruction alone, 42 underwent a biliary bypass only and 51, a biliary bypass with a prophylactic gastrojejunostomy. Operative mortality and the postoperative hospital stay were similar for these two groups; postoperative complications tended to be more common in patients undergoing the double bypass. Patients undergoing a biliary bypass alone required significantly more subsequent operations, usually for gastroduodenal obstruction. Thus, it appears that a prophylactic gastrojejunostomy should be performed upon most patients with unresectable periampullary carcinoma presenting with biliary obstruction alone to decrease the number of subsequent palliative operative procedures required.

Entities:  

Mesh:

Year:  1980        PMID: 6160629

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  7 in total

Review 1.  Current management of pancreatic carcinoma.

Authors:  K D Lillemoe
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

2.  Surgical palliation of unresectable carcinoma of the pancreas.

Authors:  M G Sarr; J L Cameron
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

3.  Surgical palliation for pancreatic cancer. The UCLA experience.

Authors:  S M Singh; W P Longmire; H A Reber
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

4.  Risk factors for morbidity and mortality following gastroenterostomy.

Authors:  Martin Poulsen; Mauro Trezza; Ghayyath H Atimash; Lars T Sorensen; Finn Kallehave; Ulla Hemmingsen; Lars N Jorgensen
Journal:  J Gastrointest Surg       Date:  2009-04-28       Impact factor: 3.452

Review 5.  Cystic duct patency in malignant obstructive jaundice. An ERCP-based study relevant to the role of laparoscopic cholecystojejunostomy.

Authors:  P R Tarnasky; R E England; L M Lail; T N Pappas; P B Cotton
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

6.  Biliary bypass and palliation for pancreatic cancer.

Authors:  C D Johnson
Journal:  J R Soc Med       Date:  1990-08       Impact factor: 18.000

7.  Palliative interventional and surgical therapy for unresectable pancreatic cancer.

Authors:  Volker Assfalg; Norbert Hüser; Christoph Michalski; Sonja Gillen; Jorg Kleeff; Helmut Friess
Journal:  Cancers (Basel)       Date:  2011-02-14       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.